Market Insights Health Hospitals Inpatient Care

Treatment of Cardiovascular Diseases - Europe

Europe

In Europe, the Treatment of Cardiovascular Diseases market is estimated to achieve a revenue of €103.90bn by the year 2025.
Furthermore, it is anticipated that the revenue will experience a compound annual growth rate (CAGR) of 3.75% from 2025 to 2029, ultimately leading to a market volume of €120.40bn by 2029.
When compared globally, United States is expected to generate the highest revenue of €127.90bn in 2025.
In Europe, the treatment of cardiovascular diseases has seen a significant rise in innovative medical technologies and personalized medicine approaches, with countries like Germany leading the way in advanced cardiac interventions.

Key regions: Germany, France, Japan, Europe, India

Mercado

Región

Comparación de regiones

Moneda

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.